Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Gambacorti-Passerini
In Vitro and in Vivo Activity of SKI-606, a Novel SRC-Abl Inhibitor, Against Imatinib-Resistant BCR-Abl+ Neoplastic Cells
Cancer Research
Cancer Research
Oncology
Alterations in Creatine Kinase, Phosphate and Lipid Values in Patients With Chronic Myeloid Leukemia During Treatment With Imatinib
Haematologica
Hematology
Related publications
Simultaneous Targeting of Aurora Kinases and BCR-Abl Kinase by the Small Molecule Inhibitor PHA-739358 Is Effective Against Imatinib-Resistant BCR-ABL Mutations Including T315I
Blood
Biochemistry
Immunology
Cell Biology
Hematology
SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Non-Atp-Competitive Inhibitor of BCR-ABL Overrides Imatinib Resistance
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
NPB001-05 Inhibits BCR-Abl Kinase Leading to Apoptosis of Imatinib-Resistant Cells
Frontiers in Bioscience - Elite
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
ON012380: A Non-Atp Competitive Inhibitor of BCR-ABL for the Therapy of Imatinib-Resistant CMLs
Effect of a Selective Abl Tyrosine Kinase Inhibitor, STI571, on in Vitro Growth of BCR-ABL-positive Acute Lymphoblastic Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Scalable and Impurity-Free Process for Dasatinib: SRC and BCR-Abl Inhibitor
Asian Journal of Chemistry
Chemistry
Development of a Protease-Resistant Reporter to Quantify BCR–ABL Activity in Intact Cells
Analyst, The
Biochemistry
Environmental Chemistry
Analytical Chemistry
Electrochemistry
Spectroscopy
Detection of Single Nucleotide Insertion of BCR/ABL Region in Imatinib-Resistant Human Myelogenous Leukemia SR-1 Cells
Experimental & Molecular Medicine
